Buy & Sell Charles Schwab Corporation Common Stock (SCHW) – Charles Schwab Corporation Common Stock Price Today
Aura AI Summary
Key Stats
- $154.50BMarket Cap
- FinancialsSector
- -14.88%3M Drawdown
- -Enterprise Value
- 1.44%Dividend Yield
- 80 daysTypical Hold Time
Charles Schwab Corporation Common Stock (SCHW) is currently valued at a market capitalization of $154.50B. Over the past 52 weeks, Charles Schwab Corporation Common Stock has traded between a low of $85.35 and a high of $107.21, highlighting its annual price range. Over the past three months, Charles Schwab Corporation Common Stock has recorded a drawdown of -14.88%, reflecting recent price volatility. Charles Schwab Corporation Common Stock offers a dividend yield of 1.44%, with the most recent dividend of $0.32 paid on 08 May 26. On average, investors hold Charles Schwab Corporation Common Stock for approximately 80 days, indicating typical investor behavior on the platform.
About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Most Recent News
Cyabra inks $500K+ deal to fight online hate with AI-powered disinformation detection for global research institute
Cyabra, an AI-driven disinformation intelligence company, has secured a contract worth over $500,000 to provide its technology to a leading international research institute focused on tracking global hate speech. The platform will help identify coord...

Ormat launches Ormega100, the largest binary geothermal unit, to boost Enhanced Geothermal System deployment.
Ormat Technologies introduced the Ormega100, the industry's largest binary power generation unit delivering 100 MW output, designed to accelerate commercialization and scaling of Enhanced Geothermal Systems (EGS). With 60 years of expertise and exten...

ADARx to present Phase 1/2 data on Onvuzosiran for hereditary angioedema at 2026 EAACI Congress
ADARx Pharmaceuticals announced it will present Phase 1/2 clinical data for Onvuzosiran, an RNA therapy for hereditary angioedema (HAE), at the 2026 EAACI Congress in Istanbul. Onvuzosiran targets plasma prekallikrein to prevent swelling attacks by r...
